| 1 |
Koyama M, Yamaguchi K, Chigusa Y, Yamanoi K, Taki M, Sunada M, Horie A, Hamanishi J, Minamiguchi S, Mandai M. ATM mutation in aggressive uterine adenosarcoma in which systemic chemotherapies had remarkable effects. Int Cancer Conf J 2023;12:120-5. [PMID: 36896195 DOI: 10.1007/s13691-022-00591-6] [Reference Citation Analysis]
|
| 2 |
Hasegawa C, Washimi K, Hiroshima Y, Kasajima R, Kikuchi K, Notomi T, Kato H, Hiruma T, Sato S, Okubo Y, Yoshioka E, Ono K, Miyagi Y, Yokose T. Differential diagnosis of uterine adenosarcoma: identification of JAZF1-BCORL1 rearrangement by comprehensive cancer genomic profiling. Diagn Pathol 2023;18:5. [PMID: 36639698 DOI: 10.1186/s13000-022-01279-4] [Reference Citation Analysis]
|
| 3 |
Hinchcliff E, Lawson B, Fleming ND. Other rare uterine sarcomas: Adenosarcoma, endometrial stromal sarcoma, STUMP. Diagnosis and Treatment of Rare Gynecologic Cancers 2023. [DOI: 10.1016/b978-0-323-82938-0.00010-0] [Reference Citation Analysis]
|
| 4 |
Paspulati RM. MRI of malignant uterine tumors. Magnetic Resonance Imaging of the Pelvis 2023. [DOI: 10.1016/b978-0-323-89854-6.00020-x] [Reference Citation Analysis]
|
| 5 |
Carreira M, Lisboa-gonçalves P, Matos M, Flores L, Cunha F, Von Hafe P. Relapsing uterine adenosarcoma presenting as pulmonary hypertension. Gazz Med Ital - Arch Sci Med 2022;181. [DOI: 10.23736/s0393-3660.21.04574-5] [Reference Citation Analysis]
|
| 6 |
Du H, Jiang J, Wang Z, Peng H. Comorbidities in patients with uterine adenosarcoma. A single-center case series of 12 patients.. [DOI: 10.21203/rs.3.rs-1983452/v2] [Reference Citation Analysis]
|
| 7 |
Hu H, Wei Z, Zhao H, Yuan G. Epidemiology of adenosarcoma and the inverse probability of treatment weighting (IPTW) adjusted survival analysis of lymph node dissection in uterine adenosarcoma. Medicine (Baltimore) 2022;101:e30607. [PMID: 36197202 DOI: 10.1097/MD.0000000000030607] [Reference Citation Analysis]
|
| 8 |
Hasegawa C, Washimi K, Hiroshima Y, Kasajima R, Kikuchi K, Notomi T, Kato H, Hiruma T, Sato S, Okubo Y, Yoshioka E, Ono K, Miyagi Y, Yokose T. Differential diagnosis of uterine adenosarcoma: identification of JAZF1-BCORL1 rearrangement by comprehensive cancer genome profiling.. [DOI: 10.21203/rs.3.rs-1995945/v1] [Reference Citation Analysis]
|
| 9 |
Du H, Jiang J, Wang Z, Peng H. Comorbidities in patients with uterine adenosarcoma. A single-center case series of 12 patients.. [DOI: 10.21203/rs.3.rs-1983452/v1] [Reference Citation Analysis]
|
| 10 |
Hao Z, Yang S. The role of postoperative radiotherapy in patients with uterine sarcomas: A PSM-IPTW analysis based on SEER database. Front Surg 2022;9. [DOI: 10.3389/fsurg.2022.985654] [Reference Citation Analysis]
|
| 11 |
Keikha F, Shooshtari M, Zamani N, Department of Obstetrics and Gynecology, Vali-e-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran, Department of Obstetrics and Gynecology, Vali-e-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran, Department of Obstetrics and Gynecology, Vali-e-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran. Uterine Rupture in Second Trimester Due to Misoprostol Use: A Case Report and Literature Review. J Obstet Gynecol Cancer Res 2022;7:243-246. [DOI: 10.30699/jogcr.7.3.243] [Reference Citation Analysis]
|
| 12 |
Hu H, Song Q, Zhao H, Zheng B, Lu H. The first successful treatment and genetic sequencing of primary hepatic adenosarcoma with sarcomatous overgrowth: a case report. J Int Med Res 2022;50:030006052210895. [DOI: 10.1177/03000605221089546] [Reference Citation Analysis]
|
| 13 |
Li JY, Mutlu L, Tymon-Rosario J, Khadraoui W, Nagarkatti N, Hui P, Buza N, Lu L, Schwartz P, Menderes G. Clinicopathologic characteristics and oncologic outcomes in adenosarcoma of gynecologic sites. Gynecol Oncol Rep 2022;39:100913. [PMID: 35005157 DOI: 10.1016/j.gore.2021.100913] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 14 |
Ashrafganjoei T, Talayeh M, Noei Teymoordash S, Hashemi Bahremani M, talayeh H, Preventative Gynecology Research Center, Imam Hossein Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Preventative Gynecology Research Center, Imam Hossein Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Shahid Beheshti University of Medical Sciences, Department of Pathology, Imam Hossein Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Velayat Medical Center, Qazvin University of Medical Science, Qazvin, Iran. Uterine Adenosarcoma: A Case Report and Review of Literature. J Obstet Gynecol Cancer Res 2022;7:59-62. [DOI: 10.30699/jogcr.7.1.59] [Reference Citation Analysis]
|
| 15 |
Kostov S, Kornovski Y, Ivanova V, Dzhenkov D, Metodiev D, Watrowski R, Ivanova Y, Slavchev S, Mitev D, Yordanov A. New Aspects of Sarcomas of Uterine Corpus-A Brief Narrative Review. Clin Pract 2021;11:878-900. [PMID: 34842646 DOI: 10.3390/clinpract11040103] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 16 |
Qu W, Liu Q, Jiao X, Zhang T, Wang B, Li N, Dong T, Cui B. Development and Validation of a Personalized Survival Prediction Model for Uterine Adenosarcoma: A Population-Based Deep Learning Study. Front Oncol 2020;10:623818. [PMID: 33680946 DOI: 10.3389/fonc.2020.623818] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 17 |
Rana IA, Hassan U, Bashir S, Hussain M, Shakeel M 4th, Mushtaq S. Müllerian Adenosarcoma: A Single-Centre Experience of 59 Cases of This Rare Entity. Cureus 2021;13:e13360. [PMID: 33747657 DOI: 10.7759/cureus.13360] [Reference Citation Analysis]
|
| 18 |
Kim J, Heo SH, Shin SS, Jeong YY. MRI Findings and Differential Diagnosis of Benign and Malignant Tumors of the Uterine Corpus. J Korean Soc Radiol 2021;82:1103. [DOI: 10.3348/jksr.2021.0116] [Reference Citation Analysis]
|
| 19 |
Sheikh Y, Alhusseiny K. Uterine sarcoma. Radiopaedia.org 2020. [DOI: 10.53347/rid-85235] [Reference Citation Analysis]
|
| 20 |
Apellaniz-Ruiz M, McCluggage WG, Foulkes WD. DICER1-associated embryonal rhabdomyosarcoma and adenosarcoma of the gynecologic tract: Pathology, molecular genetics, and indications for molecular testing. Genes Chromosomes Cancer 2021;60:217-33. [PMID: 33135284 DOI: 10.1002/gcc.22913] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 21 |
Ferrandina G, Aristei C, Biondetti PR, Cananzi FCM, Casali P, Ciccarone F, Colombo N, Comandone A, Corvo' R, De Iaco P, Dei Tos AP, Donato V, Fiore M, Franchi, Gadducci A, Gronchi A, Guerriero S, Infante A, Odicino F, Pirronti T, Quagliuolo V, Sanfilippo R, Testa AC, Zannoni GF, Scambia G, Lorusso D. Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa' italiana di Ginecologia E Ostetricia). Eur J Cancer 2020;139:149-68. [PMID: 32992154 DOI: 10.1016/j.ejca.2020.08.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 22 |
Wang B, Yang HD, Shi XH, Li H. Advanced uterine adenosarcoma with sarcomatous overgrowth in a young woman: A case report. Medicine (Baltimore) 2019;98:e18119. [PMID: 31764852 DOI: 10.1097/MD.0000000000018119] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 23 |
Abdelkader A, Giorgadze T. Retroperitoneal low grade endometrial stromal sarcoma with florid endometrioid glandular differentiation: Cytologic-histologic correlation and differential diagnosis. Ann Diagn Pathol 2019;39:25-9. [PMID: 30611894 DOI: 10.1016/j.anndiagpath.2018.12.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 24 |
Mallmann P. Uterine Sarcoma - Difficult to Diagnose, Hard to Treat. Oncol Res Treat 2018;41:674-674. [DOI: 10.1159/000494393] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
